short course neoadjuvant radiotherapy
Showing 1 - 25 of >10,000
Locally Advanced Esophageal Carcinoma Trial in Nanjing (Neoadjuvant Chemotherapy, Neoadjuvant Toripalimab, Short Course
Recruiting
- Locally Advanced Esophageal Carcinoma
- Neoadjuvant Chemotherapy
- +2 more
-
Nanjing, Jiangsu, ChinaJiangsu Cancer Hospital /Jiangsu Institute of Cancer Research
Jun 21, 2022
Rectal Cancer Trial (Short-course radiotherapy combined with furoquintinib and PD-1 mAb)
Not yet recruiting
- Rectal Cancer
- Short-course radiotherapy combined with furoquintinib and PD-1 monoclonal antibody
- (no location specified)
Aug 29, 2023
Early Low Rectal Cancer Trial in Shanghai (PD-1 antibody, Capecitabine, Oxaliplatin)
Recruiting
- Early Low Rectal Cancer
- PD-1 antibody
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jan 9, 2023
Locally Advanced Rectal Carcinoma Trial (Cadonilimab Injection, Short-course radiotherapy, Consolidation chemo)
Not yet recruiting
- Locally Advanced Rectal Carcinoma
- Cadonilimab Injection
- +2 more
- (no location specified)
Mar 19, 2023
Locally Advanced Rectal Carcinoma Trial (Short course radiotherapy with concurrent capecitabine(825mg/m2), Long course
Not yet recruiting
- Locally Advanced Rectal Carcinoma
- Short course radiotherapy with concurrent capecitabine(825mg/m2)
- Long course radiotherapy with concurrent capecitabine(825mg/m2)
- (no location specified)
Jun 24, 2023
Neoadjuvant Treatment, Rectal Cancer, Cetuximab Trial in Shanghai (cetuximab+mFOLFOX6, short-course radiotherapy)
Recruiting
- Neoadjuvant Treatment
- +3 more
- cetuximab+mFOLFOX6
- short-course radiotherapy
-
Shanghai, Shanghai, ChinaRuijin Hospital
Apr 15, 2022
Locally Advanced, High-Risk, Rectal Cancer Trial in Guangzhou (Toripalimab, short-term radiotherapy, Oxaliplatin)
Not yet recruiting
- Locally Advanced
- +3 more
- Toripalimab
- +3 more
-
Guangzhou, Guangdong, ChinaNanfang Hospital Southern Medical University
May 17, 2023
Disorder in Complete Remission in Response to Treatment Trial in Wuhan (Sintilimal Injection)
Recruiting
- Disorder in Complete Remission in Response to Treatment
- Sintilimal Injection
-
Wuhan, Hubei, ChinaRenmin Hospital of Wuhan University
Sep 28, 2022
Rectal Cancer, Locally Advanced Trial (radiation, drug, procedure)
Not yet recruiting
- Rectal Cancer
- Locally Advanced
- Short-course radiotherapy
- +3 more
- (no location specified)
Oct 8, 2022
Rectal Tumors Malignant, Radiotherapy Trial in Beijing, Shenzhen (drug, radiation, combination product)
Not yet recruiting
- Rectal Neoplasms Malignant
- Radiotherapy
- Sintilimab
- +2 more
-
Beijing, Beijing, China
- +1 more
Jul 29, 2022
Rectal Tumors Trial in Mumbai (Chlorophyllin, Sodium Copper Complex, Placebo)
Not yet recruiting
- Rectal Neoplasms
- Chlorophyllin, Sodium Copper Complex
- Placebo
-
Mumbai, Maharashtra, IndiaTata Memorial Hospital
May 3, 2023
Gastric/Gastroesophageal Junction Adenocarcinoma, Radiotherapy, Immunotherapy Trial (Envafolimab)
Not yet recruiting
- Gastric/Gastroesophageal Junction Adenocarcinoma
- +2 more
- (no location specified)
May 18, 2022
Rectal Cancer Stage II, Rectal Cancer Stage III Trial in Brussels, Kortrijk, Namur (drug, radiation, procedure)
Active, not recruiting
- Rectal Cancer Stage II
- Rectal Cancer Stage III
- Nivolumab 10 MG/ML Intravenous Solution
- +3 more
-
Brussels, Belgium
- +3 more
Jul 11, 2022
Neoadjuvant Treatment, Rectal Cancer, Bevacizumab Trial (Bevacizumab+mFOLFOX6)
Not yet recruiting
- Neoadjuvant Treatment
- +3 more
- (no location specified)
Oct 28, 2021
Locally Advanced Rectal Cancer Trial in Pisa (drug, radiation, procedure)
Recruiting
- Locally Advanced Rectal Cancer
- Irinotecan
- +5 more
-
Pisa, ItalyU.O. Oncologia Medica 2 Universitaria - Azienda Ospedaliero-Univ
Mar 9, 2022
Rectal Cancer Trial in Chengdu (drug, radiation, procedure)
Recruiting
- Rectal Cancer
- Fruquintinib
- +3 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Mar 8, 2023
Locally Advanced Rectal Cancer, Older People Trial in Belgium (radiation, drug, procedure, combination product)
Not yet recruiting
- Locally Advanced Rectal Cancer
- Older People
- Short course radiotherapy
- +3 more
-
Edegem, Antwerpen, Belgium
- +12 more
Sep 18, 2023
Rectal Cancer Trial in Wuhan (Short course radiotherapy sequential camrelizumab and chemo)
Recruiting
- Rectal Cancer
- Short course radiotherapy sequential camrelizumab and chemotherapy
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Aug 2, 2021
Rectal Tumors Trial in Beijing (SCPRT plus neoadjuvant chemo, long course chemoradiation)
Recruiting
- Rectal Neoplasms
- SCPRT plus neoadjuvant chemotherapy
- long course chemoradiation
-
Beijing, ChinaDepartment of Radiation Oncology, Cancer Institute and Hospital,
Sep 1, 2021
Rectal Cancer, Radiotherapy, Immunotherapy Trial in Wuhan (Chemotherapy, Immunotherapy, IMRT)
Active, not recruiting
- Rectal Cancer
- +3 more
- Chemotherapy
- +2 more
-
Wuhan, Hubei, ChinaCancer Center, Union Hospital, Tongji Medical College, Huazhong
Jun 19, 2021
Cancer, Rectum Trial in Beijing (Short-course radiotherapy with neoadjuvant chemo, Long-term chemoradiotherapy)
Recruiting
- Cancer, Rectum
- Short-course radiotherapy with neoadjuvant chemotherapy
- Long-term chemoradiotherapy
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences, Peking Uni
Jul 10, 2021
Locally Advanced Colon Cancer Trial (Serplulimab, short-term radiotherapy, Oxaliplatin)
Not yet recruiting
- Locally Advanced Colon Cancer
- Serplulimab
- +3 more
- (no location specified)
Feb 16, 2023
Rectal Cancer Trial in Hangzhou (Envafolimab)
Recruiting
- Rectal Cancer
-
Hangzhou, Zhejiang, ChinaSir Run Run Shaw Hospital, Zhejiang University School of Medicin
May 4, 2023
Rectal Cancer, Locally Advanced Trial in Tunis (Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan),
Active, not recruiting
- Rectal Cancer
- Locally Advanced
- Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan)
- Radiotherapy
-
Tunis, TunisiaAmel Mezlini
May 19, 2023